CT47B1

Across TCGA pan-cancer cohorts, CT47B1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated CT47B1 data layer compared with 9 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher CT47B1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CT47B1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

READ, BRCA, and COAD are the cancer types where CT47B1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	II,III,IV	0.111	0.919	<.001	45	view →
BRCA	OS	Median	All	0.198	0.924	<.001	36	view →
COAD	OS	Median	All	0.503	0.880	<.001	27	view →
UCEC	DFS	Median	All	0.925	0.620	.021	18	view →
SARC	OS	Median	All	0.174	0.860	<.001	6	view →
LIHC	DFS	Median	All	0.054	0.553	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CT47B1–READ (OS)

Open the READ breakdown →